Showing results (41-50 of 193) with videos related to
Sort By:
Pageof 20
Frontiers in Pharmacology|May 27, 2014
Sirtuin modulators control reactive gliosis in an in vitro model of Alzheimer's diseaseCaterina Scuderi, Claudia Stecca, Maria R Bronzuoli, et al.Chemotherapy|October 23, 2019
Effects of Glutathione Transferase-Targeting Nitrobenzoxadiazole Compounds in Relation to PD-L1 Status in Human Melanoma CellsFrancesca Sciarretta, Chiara Fulci, Camilla Palumbo, et al.Clinical Epigenetics|January 19, 2019
Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cellsHalina Was, Sylwia K Krol, Dante Rotili, et al.Bioorganic & Medicinal Chemistry Letters|January 2, 2007
Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicansAntonello Mai, Dante Rotili, Silvio Massa, et al.Journal of Medicinal Chemistry|January 1, 2010
Characterization of sirtuin inhibitors in nematodes expressing a muscular dystrophy protein reveals muscle cell and behavioral protection by specific sirtinol analoguesMatthieu Y Pasco, Dante Rotili, Lucia Altucci, et al.Bioorganic & Medicinal Chemistry Letters|April 25, 2008
Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferasesGianluca Sbardella, Sabrina Castellano, Caterina Vicidomini, et al.American Journal of Cancer Research|May 18, 2016
Tumour-specific metabolic adaptation to acidosis is coupled to epigenetic stability in osteosarcoma cellsTokuhiro Chano, Sofia Avnet, Katsuyuki Kusuzaki, et al.Nature Communications|November 16, 2017
Crystal structures of the mitochondrial deacylase Sirtuin 4 reveal isoform-specific acyl recognition and regulation featuresMartin Pannek, Zeljko Simic, Matthew Fuszard, et al.Medicinal Research Reviews|February 18, 2005
Histone deacetylation in epigenetics: an attractive target for anticancer therapyAntonello Mai, Silvio Massa, Dante Rotili, et al.European Journal of Medicinal Chemistry|August 19, 2007
Class II-selective histone deacetylase inhibitors. Part 2: alignment-independent GRIND 3-D QSAR, homology and docking studiesRino Ragno, Silvia Simeoni, Dante Rotili, et al.Pageof 20